Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRSP

CRISPR Therapeutics AG

May 08 • 04:00PM ET

54.83

+2.41 4.60 %

Healthcare • Biotechnology • Switzerland • Mid • NASD

Peers: NTLA BEAM EDIT PRME VRTX

| Held by: ARKK IWM ARKG XBI VXF IWN IBB SCHA VTWO SCHM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.21	Insider Own	7.19%	Shs Outstand	96.39M	Perf Week	6.20%
Market Cap	5.29B	Forward P/E	-	EPS next Y	-3.82	Insider Trans	-3.19%	Shs Float	89.52M	Perf Month	6.01%
Enterprise Value	3.63B	PEG	-	EPS next Q	-1.17	Inst Own	65.91%	Short Float	25.42%	Perf Quarter	12.49%
Income	-568.53M	P/S	1289.83	EPS this Y	25.26%	Inst Trans	4.78%	Short Ratio	11.88	Perf Half Y	-3.79%
Sales	4.10M	P/B	2.91	EPS next Y	20.98%	ROA	-23.24%	Short Interest	22.75M	Perf YTD	4.56%
Book/sh	18.83	P/C	2.17	EPS next 5Y	27.58%	ROE	-31.21%	52W High	78.48 -30.14%	Perf Year	51.72%
Cash/sh	25.32	P/FCF	-	EPS past 3/5Y	8.21% -4.10%	ROIC	-22.01%	52W Low	34.12 60.70%	Perf 3Y	-2.02%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	43.09% 37.31%	Gross Margin	-5283.40%	Volatility	6.62% 5.69%	Perf 5Y	-49.09%
Dividend TTM	-	EV/Sales	886.28	EPS Y/Y TTM	-37.55%	Oper. Margin	-13408.29%	ATR (14)	3.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.96	Sales Y/Y TTM	-89.11%	Profit Margin	-13856.54%	RSI (14)	54.31	Recom	1.93
Dividend Gr. 3/5Y	- -	Current Ratio	17.96	EPS Q/Q	19.13%	SMA20	1.37%	Beta	1.74	Target Price	78.91
Payout	-	Debt/Eq	0.43	Sales Q/Q	68.55%	SMA50	5.01%	Rel Volume	0.90	Prev Close	52.42
Employees	-	LT Debt/Eq	0.42	Earnings	May 04 AMC	SMA200	-2.44%	Avg Volume	1.91M	Price	54.83
IPO	Oct 19, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.05% -75.96%	Trades		Volume	1,726,683	Change	4.60%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)